Los Angeles, CALIFORNIA3 Active Studies

Nephrotic Syndrome Clinical Trials in Los Angeles, CALIFORNIA

Find 3 actively recruiting nephrotic syndrome clinical trials in Los Angeles, CALIFORNIA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
614
Enrolling

Recruiting Nephrotic Syndrome Studies in Los Angeles

About Nephrotic Syndrome Clinical Trials in Los Angeles

Nephrotic syndrome is a kidney disorder characterized by heavy proteinuria, low blood albumin, high cholesterol, and swelling. It can be caused by various underlying conditions. Treatment targets the underlying cause and may include immunosuppressive medications and supportive care.

There are currently 3 nephrotic syndrome clinical trials recruiting participants in Los Angeles, CALIFORNIA. These studies are seeking a combined 614 participants. Research is being sponsored by Dimerix Bioscience Pty Ltd, Biogen, Cerium Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Nephrotic Syndrome Clinical Trials in Los Angeles — FAQ

Are there nephrotic syndrome clinical trials in Los Angeles?

Yes, there are 3 nephrotic syndrome clinical trials currently recruiting in Los Angeles, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What nephrotic syndrome treatments are being tested?

The 3 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for nephrotic syndrome.

Data updated March 2, 2026 from ClinicalTrials.gov